IL3 and leukemia: CSL 360 is a recombinant chimeric immunoglobulin G 1 anti CD123 monoclonal antibody, which can recognize the CD123(+)/CD131(–) phenotype expressed by LSCs exhibiting anti leukemia activity by neutralizing IL-3 to prevent IL-3 binding to its receptor (38, 39).